SAM
Sectoral Asset Management Portfolio holdings
AUM
$151M
This Quarter Return
+4.36%
1 Year Return
+14.02%
3 Year Return
+79.35%
5 Year Return
+153.48%
10 Year Return
+511.68%
AUM
$912M
AUM Growth
+$912M
(+14%)
Cap. Flow
+$98.3M
Cap. Flow
% of AUM
10.78%
Top 10 Holdings %
Top 10 Hldgs %
35.88%
Holding
80
New
13
Increased
28
Reduced
21
Closed
12
Top Buys
| 1 |
ARRY
Array Biopharma Inc
ARRY
|
$16.8M |
| 2 |
Gilead Sciences
GILD
|
$15.5M |
| 3 |
Exact Sciences
EXAS
|
$15.4M |
| 4 |
PRAH
PRA Health Sciences, Inc.
PRAH
|
$12.5M |
| 5 |
Cogent Biosciences
COGT
|
$12M |
Top Sells
| 1 |
XLRN
Acceleron Pharma Inc.
XLRN
|
$19.1M |
| 2 |
Regeneron Pharmaceuticals
REGN
|
$14.8M |
| 3 |
LOXO
Loxo Oncology, Inc
LOXO
|
$12.8M |
| 4 |
GBT
Global Blood Therapeutics, Inc.
GBT
|
$12.3M |
| 5 |
AbbVie
ABBV
|
$8.25M |
Sector Composition
| 1 | Healthcare | 91.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
WMGI
51
DELISTED
Wright Medical Group Inc
WMGI
| $6.1M | 0.67% |
307,672
-300
| -0.1% | -$5.95K |
|
52
Evolent Health
EVH
$1.11B
| $6.04M | 0.66% |
423,482
-68,500
| -14% | -$976K |
|
53
Madrigal Pharmaceuticals
MDGL
$9.7B
| $5.92M | 0.65% |
50,649
+13,799
| +37% | +$1.61M |
|
|
ALBO
54
DELISTED
Albireo Pharma, Inc. Common Stock
ALBO
| $5.63M | 0.62% |
172,803
-70,000
| -29% | -$2.28M |
|
|
SAGE
55
DELISTED
Sage Therapeutics
SAGE
| $5.25M | 0.58% |
32,600
+15,400
| +90% | +$2.48M |
|
|
MNTA
56
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
| $4.8M | 0.53% |
264,699
-235,599
| -47% | -$4.28M |
|
57
Q32 Bio
QTTB
$20.9M
| $4.21M | 0.46% |
+225,000
| New | +$4.21M |
|
58
Rocket Pharmaceuticals
RCKT
$358M
| $4.05M | 0.44% |
+216,158
| New | +$4.05M |
|
|
OBSV
59
DELISTED
ObsEva SA Ordinary Shares
OBSV
| $3.91M | 0.43% |
289,507
+78,100
| +37% | +$1.05M |
|
60
Indaptus Therapeutics
INDP
$5.98M
| $2.85M | 0.31% |
451,252
+96,252
| +27% | +$611K |
|
|
AVXS
61
DELISTED
AveXis, Inc. Common Stock
AVXS
| $2.73M | 0.3% |
+22,120
| New | +$2.73M |
|
62
Savara
SVRA
$591M
| $2.51M | 0.28% |
273,000
+113,000
| +71% | +$1.04M |
|
|
FSTX
63
DELISTED
F-star Therapeutics, Inc. Common Stock
FSTX
| $2.03M | 0.22% |
131,656
+8,273
| +7% | +$127K |
|
64
Accuray
ARAY
$165M
| $1.92M | 0.21% |
384,547
-210,900
| -35% | -$1.05M |
|
|
CMTA
65
DELISTED
Clementia Pharmaceuticals Inc.
CMTA
| $1.7M | 0.19% |
112,213
+36,900
| +49% | +$559K |
|
66
Zai Lab
ZLAB
$3.48B
| $1.06M | 0.12% |
49,584
| – | – |
|
67
Dr. Reddy's Laboratories
RDY
$11.8B
| $833K | 0.09% |
25,496
| – | – |
|
|
SRRA
68
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
| $417K | 0.05% |
201,660
| – | – |
|
|
69
AbbVie
ABBV
$374B
| – | – |
-85,298
| Closed | -$8.25M |
|
70
Acadia Healthcare
ACHC
$2.15B
| – | – |
-126,602
| Closed | -$4.13M |
|
71
Agios Pharmaceuticals
AGIO
$2.36B
| – | – |
-47,799
| Closed | -$2.73M |
|
|
DBVT
72
DBV Technologies
DBVT
$249M
| – | – |
-60,298
| Closed | -$1.48M |
|
73
Insmed
INSM
$30.3B
| – | – |
-90,199
| Closed | -$2.81M |
|
74
Merck
MRK
$210B
| – | – |
-108,501
| Closed | -$6.11M |
|
75
Puma Biotechnology
PBYI
$258M
| – | – |
-15,050
| Closed | -$1.49M |
|